Startups & Scaleups
-
Accelerate MVP timelines
-
Avoid integration delays
-
Retain full control of your IP
Solutions
(121 results)
Articles
(21 results)
Content
(21 results)
With Cosylab’s quantum engineering services, you can move from prototype to product-ready, from idea to proof of concept to certification.
Technical Lead
System upgrades, customisation, scaling up, and technically challenging integrations of devices into one system
Emerging quantum technologies and how they are supported by enabling technologies for different applications and use cases
Strategic Account Manager
Commercialising and scaling quantum technologies – projects that transition from lab prototypes to robust, industrial-grade systems in computing, sensing, and communication
Public or grant-funded collaboration opportunities in quantum
Partnerships and go-to-market planning for quantum projects
Subscribe to our newsletter, and we will update you on all things Quantum.
15.06.2023
Subscribe to our newsletter, and stay in the know.
Cosylab is the leading provider of cutting-edge expertise, turnkey software solutions, and electronics for the world’s most advanced systems and devices, such as particle accelerators, large telescope arrays, fusion reactors, quantum technology, innovative medical devices and cancer therapy systems. Our turnkey software solutions enable organisations to make scientific breakthroughs, deliver state-of-the-art cancer treatments, develop healthcare innovations and bring clean fusion energy to the world.
With our unique end-to-end capabilities, we help organisations of all sizes and scopes accelerate development and shorten time-to-market. Our solutions are integrated into the most significant Big Science international projects, including CERN and ITER, and transformative quantum initiatives. We provide software products and services to the largest medical device manufacturers and cancer centres worldwide, such as Varian and MGH. Our engineering expertise helps innovative medical start-ups get their medical devices to patients faster.
From our headquarters in the EU and subsidiaries across Europe, North America and Asia, we have worked on hundreds of multi-year and multi-people projects worldwide.